MARSHALL WACE, LLP

Position in RCEL — AVITA Medical, Inc.

CIK 1318757 LONDON, X0

Position in RCEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,397,537

+$1,203,058 QoQ

Shares Held

338,387

+543.8% QoQ

Ownership

1.09%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 73 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. RCEL ranks #37 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	5,542,438	$502,920,823
2	BSX	Boston Scientific Corp	2,414,223	$103,039,037
3	GKOS	GLAUKOS Corp	314,804	$43,997,006
4	DXCM	Dexcom Inc	532,804	$35,884,349
5	EW	Edwards Lifesciences Corp	344,361	$31,150,895
6	PEN	Penumbra Inc	90,520	$28,581,689
7	SYK	Stryker Corp	51,116	$16,093,361
8	GMED	Globus Medical Inc	188,541	$14,896,623

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,397,537	338,387	+543.8%	Shares	Other	2026-08-13
2026-03-31	$194,479	52,562	+22.8%	Shares	Other	2026-05-15
2025-09-30	$218,743	42,807	-44.3%	Shares	Other	2025-11-13
2025-06-30	$406,404	76,825	-32.7%	Shares	Other	2025-08-13
2025-03-31	$928,708	114,092	+751.1%	Shares	Other	2025-05-15
2023-09-30	$195,861	13,406	-47.4%	Shares	Other	2023-11-14
2023-06-30	$433,755	25,500	-58.7%	Shares	Other	2023-08-14
2023-03-31	$862,158	61,715	-2.8%	Shares	Other	2023-05-15
2022-12-31	$418,928	63,474	+338.0%	Shares	Other	2023-02-14
2022-09-30	$76,367	14,491	-53.0%	Shares	Other	2022-11-14
2021-06-30	$632,590	30,828	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.